gemcabene has been researched along with Elevated Cholesterol in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bays, HE; Dujovne, CA; MacDougall, DE; McKenney, JM; Nyberg, J; Schrott, HG; Zema, MJ | 1 |
Bakker-Arkema, R; Hartman, D; Hermann, D; Mandema, JW; Milad, M; Sheiner, T; Wang, W | 1 |
Amantea, M; Benincosa, LJ; Corrigan, BW; Ewy, W; Glue, P; Hutmacher, MM; Koide, H; Kowalski, KG; Lalonde, RL; Lockwood, PA; Marshall, SA; Miller, R; Milligan, PA; Nichols, DJ; Parivar, K; Tensfeldt, TG | 1 |
2 review(s) available for gemcabene and Elevated Cholesterol
Article | Year |
---|---|
Model-based development of gemcabene, a new lipid-altering agent.
Topics: Caproates; Dose-Response Relationship, Drug; Drugs, Investigational; Humans; Hypercholesterolemia; Hypolipidemic Agents; Models, Theoretical; Randomized Controlled Trials as Topic | 2005 |
Model-based drug development.
Topics: Alzheimer Disease; Amines; Analgesics; Animals; Anticholesteremic Agents; Bridged Bicyclo Compounds, Heterocyclic; Caproates; Cholesterol; Clinical Trials as Topic; Cognition; Computer Simulation; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Drug Approval; Drug Design; Gabapentin; gamma-Aminobutyric Acid; Glycoproteins; Guidelines as Topic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Immunologic Factors; Meta-Analysis as Topic; Models, Biological; Models, Statistical; Muscarinic Agonists; Neuralgia, Postherpetic; Neutrophil Infiltration; Oximes; Pharmacokinetics; Pharmacology; Reproducibility of Results; Research Design; Stroke; United States; United States Food and Drug Administration | 2007 |
1 trial(s) available for gemcabene and Elevated Cholesterol
Article | Year |
---|---|
Effectiveness and tolerability of a new lipid-altering agent, gemcabene, in patients with low levels of high-density lipoprotein cholesterol.
Topics: Aged; Analysis of Variance; Anticholesteremic Agents; Apolipoprotein A-I; Apolipoprotein A-II; Apolipoproteins B; Apolipoproteins C; Apolipoproteins E; Caproates; Cholesterol, HDL; Cholesterol, LDL; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hypercholesterolemia; Hypertriglyceridemia; Male; Middle Aged; Treatment Outcome; Triglycerides | 2003 |